BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33941714)

  • 1. Short-Term Outcomes of Pediatric Keratoprosthesis With the Near-Complete Conjunctival Flap.
    Bawany MH; Kudla C; Khan FA; Chung MM; Aquavella JV
    Cornea; 2021 Jun; 40(6):679-684. PubMed ID: 33941714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of clinic results and complication associated with Boston I keratoprosthesis].
    Wang L; Bai H; Huang Y
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):673-6. PubMed ID: 26693652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology.
    Lee WB; Shtein RM; Kaufman SC; Deng SX; Rosenblatt MI
    Ophthalmology; 2015 Jul; 122(7):1504-11. PubMed ID: 25934510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
    Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
    Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term prognosis of type I Boston keratoprosthesis reimplantation.
    Bouhout S; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jan; 106(1):37-41. PubMed ID: 33055084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and complications of Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis following ocular surface burns: clinical experience in China.
    Wang L; Huang Y; Du G; Dong Y; Guo H; Wang D; Yu J; Wang Q; Chen B; Hou L
    Br J Ophthalmol; 2015 Dec; 99(12):1669-74. PubMed ID: 26034080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Boston keratoprosthesis: 73 eyes from Germany : An overview of experiences from two centers].
    Schaub F; Neuhann I; Enders P; Bachmann BO; Koller B; Neuhann T; Cursiefen C
    Ophthalmologe; 2018 Sep; 115(9):744-753. PubMed ID: 29043440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort.
    Srikumaran D; Munoz B; Aldave AJ; Aquavella JV; Hannush SB; Schultze R; Belin M; Akpek EK
    Ophthalmology; 2014 Nov; 121(11):2159-64. PubMed ID: 25017414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.